November 21, 2016
(Managed Care Magazine) – The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, the World Health Organization (WHO) has announced. Funding is now secured for the initial phase of the program, and vaccinations are due to begin in 2018. The vaccine, known as RTS,S, acts against Plasmodium falciparum, the most deadly malaria parasite globally, and the most prevalent in Africa. Advanced clinical trials have shown RTS,S to provide partial protection against malaria in young children.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.